Literature DB >> 21835699

Mycobacterium tuberculosis Beijing genotype: a template for success.

M Hanekom1, N C Gey van Pittius, C McEvoy, T C Victor, P D Van Helden, R M Warren.   

Abstract

The diverse clinico- and histopathological features, frequency of transmission and treatment outcome of Mycobacterium tuberculosis have been associated with several environmental, host and bacterial factors. Many Mycobacterium tuberculosis genotypes have been studied in an attempt to understand the genetic variations among the different genotypes and to clarify their contribution to phenotypic differences. Strains of the Beijing genotype have been extensively investigated due to their increased ability to spread and cause disease. Here we review the evidence of hypervirulence of the Beijing genotype as well as other Beijing-associated phenotypic characteristics such as alternate host immune modulation, clinical and pathological features, drug resistance, resistance to BCG vaccination and other epidemiological features to enhance our understanding of the contribution of pathogenic factors. From the data collected it is clear that the genetic background of Mycobacterium tuberculosis may influence the differential induction of the immune response, drug resistance patterns and clinical, epidemiological and pathogenic features which define disease progression following infection. This highlights the importance of ongoing research into the genetic mechanisms underlying the phenotypic and genotypic characteristics of different Mycobacterium tuberculosis genotype strains. Furthermore, these findings could help to direct future drug, vaccine and diagnostic test development towards targeting critical virulence factors and to identify persons at risk for developing active disease thereby limiting transmission and the perpetuation of the tuberculosis epidemic.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21835699     DOI: 10.1016/j.tube.2011.07.005

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN: 1472-9792            Impact factor:   3.131


  61 in total

1.  The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.

Authors:  Gwenan M Knight; Caroline Colijn; Sourya Shrestha; Mariam Fofana; Frank Cobelens; Richard G White; David W Dowdy; Ted Cohen
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

Review 2.  Origin and proliferation of multiple-drug resistance in bacterial pathogens.

Authors:  Hsiao-Han Chang; Ted Cohen; Yonatan H Grad; William P Hanage; Thomas F O'Brien; Marc Lipsitch
Journal:  Microbiol Mol Biol Rev       Date:  2015-03       Impact factor: 11.056

3.  Epidemic spread of multidrug-resistant tuberculosis in Johannesburg, South Africa.

Authors:  Ben J Marais; Charmaine K Mlambo; Nalin Rastogi; Thierry Zozio; Adriano G Duse; Thomas C Victor; Else Marais; Robin M Warren
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

4.  Consequences of noncompliance for therapy efficacy and emergence of resistance in murine tuberculosis caused by the Beijing genotype of Mycobacterium tuberculosis.

Authors:  Jurriaan E M de Steenwinkel; Marian T ten Kate; Gerjo J de Knegt; Henri A Verbrugh; Rob E Aarnoutse; Martin J Boeree; Michael A den Bakker; Dick van Soolingen; Irma A J M Bakker-Woudenberg
Journal:  Antimicrob Agents Chemother       Date:  2012-07-16       Impact factor: 5.191

5.  Toll-like Receptor 2 Prevents Neutrophil-Driven Immunopathology during Infection with Mycobacterium tuberculosis by Curtailing CXCL5 Production.

Authors:  Archana Gopalakrishnan; Jillian Dietzold; Sheetal Verma; Madhuri Bhagavathula; Padmini Salgame
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

6.  Analysis of mutations in streptomycin-resistant strains reveals a simple and reliable genetic marker for identification of the Mycobacterium tuberculosis Beijing genotype.

Authors:  Cristina Villellas; Liselotte Aristimuño; María-Asunción Vitoria; Cristina Prat; Silvia Blanco; Darío García de Viedma; José Domínguez; Sofía Samper; José A Aínsa
Journal:  J Clin Microbiol       Date:  2013-04-24       Impact factor: 5.948

7.  Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate.

Authors:  Susan L Baldwin; Valerie A Reese; Po-Wei D Huang; Elyse A Beebe; Brendan K Podell; Steven G Reed; Rhea N Coler
Journal:  Clin Vaccine Immunol       Date:  2015-12-09

8.  Differential virulence and disease progression following Mycobacterium tuberculosis complex infection of the common marmoset (Callithrix jacchus).

Authors:  Laura E Via; Danielle M Weiner; Daniel Schimel; Philana Ling Lin; Emmanuel Dayao; Sarah L Tankersley; Ying Cai; M Teresa Coleman; Jaime Tomko; Praveen Paripati; Marlene Orandle; Robin J Kastenmayer; Michael Tartakovsky; Alexander Rosenthal; Damien Portevin; Seok Yong Eum; Saher Lahouar; Sebastien Gagneux; Douglas B Young; Joanne L Flynn; Clifton E Barry
Journal:  Infect Immun       Date:  2013-05-28       Impact factor: 3.441

9.  Simple multiplex PCR assay for identification of Beijing family Mycobacterium tuberculosis isolates with a lineage-specific mutation in Rv0679c.

Authors:  Chie Nakajima; Aki Tamaru; Zeaur Rahim; Ajay Poudel; Bhagwan Maharjan; Hong Ling; Toshio Hattori; Tomotada Iwamoto; Yukari Fukushima; Haruka Suzuki; Yasuhiko Suzuki; Takashi Matsuba
Journal:  J Clin Microbiol       Date:  2013-04-17       Impact factor: 5.948

10.  Protection by novel vaccine candidates, Mycobacterium tuberculosis ΔmosR and ΔechA7, against challenge with a Mycobacterium tuberculosis Beijing strain.

Authors:  Sarah A Marcus; Howard Steinberg; Adel M Talaat
Journal:  Vaccine       Date:  2015-09-09       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.